Overview of acyclovir pharmacokinetic disposition in adults and children.
about
Evaluation of the polymerase chain reaction for diagnosis of herpes simplex virus encephalitisAcyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokineticsPharmacokinetics of oral acyclovir (Zovirax) in the eye.Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapyPharmacokinetics of oral acyclovir in neonates and in infants: a population analysis.Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study.Population pharmacokinetics of intravenous acyclovir in preterm and term infants.Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Continuous infusion of high-dose acyclovir for serious herpesvirus infections.Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.Pharmacokinetics of acyclovir suspension in infants and children.Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients.A case of herpes zoster associated encephalitis with rapid response to acyclovir.Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.Valacyclovir as Initial Treatment for Acute Retinal Necrosis: A Pharmacokinetic Modeling and Simulation Study.A competitive enzyme-linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine.Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis.Colloidal dispersions for the delivery of acyclovir: a comparative study.Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.
P2860
Q27487573-969BBB29-DDAE-4EB2-8754-8B9CDEB1E100Q28353263-459CC0C4-88C3-4D39-A4AA-E09644C3447FQ33643138-41CC7B14-AB02-4A36-AD35-C3015CF409AAQ33754585-8C368F36-4BBF-4F3E-8FD1-ABB00E8D723BQ33776931-6918C3F7-C591-4502-976C-5C7E0E3696EBQ33884052-F7DB89F9-2906-4E83-AB70-FB1A79970815Q33981154-DB04AD3C-F839-42E0-8643-4AAB1F99CF53Q34152542-EE5F433A-D6AE-4697-928E-44805E214A88Q34392526-4ED2EF35-FA0B-49CF-B191-CDC26AE7C615Q35121549-73E6DF84-A986-4A92-AA1C-F03935BEF20CQ35155913-23004085-4AC4-4A92-807E-F8E5C088C5B3Q35345243-0D9DC360-A393-4055-912C-BEB7DDB71023Q35541334-B3B86774-B14C-4DEE-B6B3-403201B4F5CBQ35543240-EB53FDC7-1F25-4260-AC64-A0999E80B2D1Q35646034-D818D181-2D7B-4A08-AB21-64F5A4CF4A77Q36261735-615B9F4C-823F-469F-8AE2-E4ED1238E455Q36644718-E6E933BE-2895-4E75-B101-9EB95E9391BBQ36706034-B3F513F7-35F0-493E-B5E3-78603351628FQ37410629-8B1A1347-D721-4F39-9B2A-BEE7FDAE225BQ38867550-3DFE47EF-C105-401F-8211-73B95A6AE397Q39850729-B300F879-DA3F-4ED8-B564-CCB6E0C21151Q40180848-84B7D628-C4A7-4383-80FC-FEB5A5EC9C11Q41612313-9F132803-27AB-41CE-B102-CE5E2C09F2F7Q42286838-49DC7F67-A2EC-4138-AF3E-BF4D7AB5C2BE
P2860
Overview of acyclovir pharmacokinetic disposition in adults and children.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Overview of acyclovir pharmacokinetic disposition in adults and children.
@en
type
label
Overview of acyclovir pharmacokinetic disposition in adults and children.
@en
prefLabel
Overview of acyclovir pharmacokinetic disposition in adults and children.
@en
P2093
P1476
Overview of acyclovir pharmacokinetic disposition in adults and children
@en
P2093
P304
P356
10.1016/0002-9343(82)90088-2
P407
P577
1982-07-01T00:00:00Z